Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Optimizing therapeutic efficacy of chemopreventive agents: A critical review of delivery strategies in oral cancer chemoprevention clinical trials.

Holpuch AS, Desai KG, Schwendeman SP, Mallery SR.

J Carcinog. 2011;10:23. doi: 10.4103/1477-3163.85185. Epub 2011 Sep 21.

PMID:
22013393
[PubMed]
Free PMC Article
2.

Chemoprevention of oral cancer: Green tea experience.

Ramshankar V, Krishnamurthy A.

J Nat Sci Biol Med. 2014 Jan;5(1):3-7. doi: 10.4103/0976-9668.127272. Review.

PMID:
24678188
[PubMed]
Free PMC Article
3.

Chemoprevention of premalignant and malignant lesions of oral cavity: Recent trends.

Bodhade AS, Dive AM.

Eur J Dent. 2013 Apr;7(2):246-50. doi: 10.4103/1305-7456.110198. Review.

PMID:
24883036
[PubMed]
Free PMC Article
4.

Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.

Armstrong WB, Wan XS, Kennedy AR, Taylor TH, Meyskens FL Jr.

Laryngoscope. 2003 Oct;113(10):1687-702. Review.

PMID:
14520092
[PubMed - indexed for MEDLINE]
5.

Development of chemopreventive agents for lung and upper aerodigestive tract cancers.

Kelloff GJ, Boone CW, Steele VK, Perloff M, Crowell J, Doody LA.

J Cell Biochem Suppl. 1993;17F:2-17. Review.

PMID:
8412195
[PubMed - indexed for MEDLINE]
6.

Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.

Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC.

Cancer Res. 1994 Apr 1;54(7 Suppl):2015s-2024s. Review.

PMID:
8137331
[PubMed - indexed for MEDLINE]
Free Article
7.

Development of chemopreventive agents for bladder cancer.

Kelloff GJ, Boone CW, Malone WF, Steele VE, Doody LA.

J Cell Biochem Suppl. 1992;16I:1-12. Review.

PMID:
1305671
[PubMed - indexed for MEDLINE]
8.

Retinoids: application in premalignant lesions and oral cancer.

Contreras Vidaurre EG, Bagán Sebastián JV, Gavalda C, Torres Cifuentes EF.

Med Oral. 2001 Mar-Apr;6(2):114-23. Review. English, Spanish.

PMID:
11500628
[PubMed - indexed for MEDLINE]
9.

Chemoprevention of prostate cancer: concepts and strategies.

Kelloff GJ, Lieberman R, Steele VE, Boone CW, Lubet RA, Kopelovitch L, Malone WA, Crowell JA, Sigman CC.

Eur Urol. 1999;35(5-6):342-50. Review.

PMID:
10325487
[PubMed - indexed for MEDLINE]
10.

The chemopreventive properties and therapeutic modulation of green tea polyphenols in oral squamous cell carcinoma.

Lee UL, Choi SW.

ISRN Oncol. 2011;2011:403707. doi: 10.5402/2011/403707. Epub 2011 May 16.

PMID:
22084729
[PubMed]
Free PMC Article
11.

Risk biomarkers and current strategies for cancer chemoprevention.

Kelloff GJ, Boone CW, Crowell JA, Nayfield SG, Hawk E, Malone WF, Steele VE, Lubet RA, Sigman CC.

J Cell Biochem Suppl. 1996;25:1-14. Review.

PMID:
9027592
[PubMed - indexed for MEDLINE]
12.

Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.

Kelloff GJ, Boone CW, Crowell JA, Nayfield SG, Hawk E, Steele VE, Lubet RA, Sigman CC.

J Cell Biochem Suppl. 1995;23:1-9. Review.

PMID:
8747372
[PubMed - indexed for MEDLINE]
13.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
[PubMed - indexed for MEDLINE]
14.

Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study.

Benner SE, Winn RJ, Lippman SM, Poland J, Hansen KS, Luna MA, Hong WK.

J Natl Cancer Inst. 1993 Jan 6;85(1):44-7.

PMID:
8416256
[PubMed - indexed for MEDLINE]
15.

Drug development for cancer chemoprevention: focus on molecular targets.

Johnson KA, Brown PH.

Semin Oncol. 2010 Aug;37(4):345-58. doi: 10.1053/j.seminoncol.2010.05.012. Review.

PMID:
20816505
[PubMed - indexed for MEDLINE]
16.

Chemoprevention for prostatic intraepithelial neoplasia.

Nelson PS, Gleason TP, Brawer MK.

Eur Urol. 1996;30(2):269-78. Review.

PMID:
8875211
[PubMed - indexed for MEDLINE]
17.

Introductory remarks: development of chemopreventive agents for prostate cancer.

Kelloff GJ, Boone CW, Malone WF, Steele VE, Doody LA.

J Cell Biochem Suppl. 1992;16H:1-8. Review.

PMID:
1289663
[PubMed - indexed for MEDLINE]
18.

Chemoprevention of squamous cell carcinoma of the head and neck.

Wrangle JM, Khuri FR.

Curr Opin Oncol. 2007 May;19(3):180-7. Review.

PMID:
17414634
[PubMed - indexed for MEDLINE]
19.

Chemoprevention of epithelial cancers.

Shureiqi I, Brenner DE.

Curr Opin Oncol. 1999 Sep;11(5):408-13. Review.

PMID:
10505781
[PubMed - indexed for MEDLINE]
20.

Optimal chemotherapy treatment for women with recurrent ovarian cancer.

Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, Bryson P.

Curr Oncol. 2007 Oct;14(5):195-208.

PMID:
17938703
[PubMed]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk